1
|
{miR-100}→ {miR-125b}
|
urothelial(U,U)
|
[75]
|
2
|
{miR-125b, let-7a-2} → {miR-21}
|
HCC(D,D,U)
|
[76]
|
4
|
{miR-143}→ {miR-21}
|
oral squamous cell carcinoma(D,U)
|
[77]
|
4
|
{miR-143}→ {miR-21}
|
HCC(D,U)
|
[76]
|
5
|
{miR-143, miR-145} → {miR-21, miR-125b}
|
oral squamous cell carcinoma(D,D,U,D)
|
[77]
|
5
|
{miR-143, miR-145} → {miR-21, miR-125b}
|
prostate(D,D,U,D)
|
[21, 78–80]
|
5
|
{miR-143, miR-145} → {miR-21, miR-125b}
|
HCC(D,D,U,D)
|
[76]
|
6
|
{miR-17-5p, miR-20a} → {miR-143, miR-145}
|
leukemia(U,U,D,D)
|
[81, 82]
|
8
|
{miR-101, miR-210} → {let-7a-2}
|
colon(D,U,D)
|
[83–85]
|
8
|
{miR-101, miR-210} → {let-7a-2}
|
prostate(D,U,D)
|
[83, 86]
|
8
|
{miR-101, miR-210} → {let-7a-2}
|
melanoma(D,U,D)
|
[42, 83, 84, 87]
|
8
|
{miR-101, miR-210} → {let-7a-2}
|
HCC(D,U,D)
|
[76]
|